Sour orange
StarCitrus × aurantium
Synonyms: Citrus × kotokan, Citrus × bigaradia var. florifera, Citrus × karna, Citrus × aurantium var. sigillata, Citrus × vulgaris var. hispanica, Citrus × aurantium var. lusitanica, Citrus × ujukitsu, Citrus × daidai, Citrus × bigaradia var. bifera, Citrus medica f. tamurana, Citrus × aurantium var. myrtifolia, Aurantium × orientale, Citrus × bigaradia var. bizarria, Citrus × bigaradia var. racemosus, Citrus × leiocarpa, Citrus sabon f. jiyu, Citrus decumana var. panuban, Citrus × aurantium var. corniculata, Citrus × aurantium var. fructo-aurata, Citrus × aurantium var. pyramidalis, Citrus × aurantium subsp. sinensis, Citrus taragayo, Citrus × bigaradia var. duplex, Citrus × vulgaris var. chinensis, Citrus × myrtifolia, Citrus × bigaradia var. florentina, Citrus grandis var. tengu, Citrus × aurantium var. rugosa, Citrus × vulgaris var. florifera, Aurantium × variegatum, Citrus × aurantium var. lunata, Citrus × bigaradia var. asperma, Citrus × sinograndis, Citrus × canaliculata, Citrus × anonyma, Citrus × bigaradia var. neapolitana, Aurantium × myrtifolium, Citrus × aurantium var. conifera, Citrus × bigaradia var. bigamia, Citrus × aurantium var. ilicifolia, Citrus × aurantium var. praecox, Citrus × rokugatsu, Citrus × pseudograndis, Citrus × bigaradia var. dulcis, Citrus × natsudaidai, Citrus × reshni, Citrus × panuban, Citrus × sinensis subsp. fetifera, Citrus × bigaradia var. fetifera, Citrus × aurantium var. longifolia, Citrus × nobilis var. rubrifrons, Citrus × aurantium var. angustifolia, Citrus × aurantium subsp. suntra, Citrus × sinensis, Citrus × vulgaris var. multiflora, Citrus × aurantium var. bigaradia, Citrus × bigaradia var. macrocarpa, Citrus sabon f. banyu, Citrus pompelmos var. racemosa, Citrus × intermedia, Citrus × aurantium var. oryza, Citrus × bigaradia var. myrtifolia, Citrus × aurantium var. colla, Citrus sabon f. sekitoyu, Aurantium × corniculatum, Citrus × aurantium var. fructo-depressa, Citrus × aurantium var. reshni, Citrus decumana var. racemosa, Citrus × aurantium var. natsudaidai, Citrus × bigaradia var. crispifolia, Citrus × sinensis var. vulgaris, Citrus × maderaspatana, Aurantium × sinense, Citrus × subcompressa, Citrus × aurantium var. latifolia, Citrus × sinensis subsp. crassa, Citrus × bigaradia var. fasciata, Citrus × aurantium var. genuensis, Citrus × bigaradia, Citrus × clementina, Citrus × tangelo, Citrus × vulgaris var. folio-crispa, Citrus × bigaradia var. longifolia, Citrus grandis f. benikawa, Aurantium × silvestre, Citrus × aurantium var. oblonga, Citrus × aurantium f. natsudaidai, Citrus sabon f. mitsuyu, Citrus × bigaradia var. multiflora, Citrus × aurantium var. carnosa, Citrus × aurantium var. hierochuntica, Citrus decumana var. paradisi, Aurantium × bigarella, Citrus × aurantium var. fructo-costata, Citrus × benikoji, Citrus × yuge-hyokan, Citrus grandis var. brunneorugosa, Citrus × sinensis var. variegata, Citrus × bigaradia var. sylvestris, Citrus × changshan-huyou, Citrus × bigaradia var. cortice-aeduli, Citrus × florida, Citrus × racemosa, Citrus × sinensis subsp. lusitanica, Citrus × aurantium var. sinensis, Citrus × nobilis var. subcompressa, Citrus × aurantium var. nicaensis, Citrus × aurantium var. imbiga, Citrus × aurantium var. daidai, Citrus × glaberrima, Citrus × amara, Citrus × aurantium var. voangkely, Citrus × asahikan, Citrus × aurantium subsp. natsudaidai, Citrus × vulgaris var. corniculata, Citrus × bigaradia var. itan, Citrus × iwaikan, Citrus × aurantium var. nobilis, Citrus × bigaradia var. mammillata, Citrus × aurantium var. asperma, Citrus × oto, Citrus × aurantium var. duplex, Citrus × aurantium var. fetifera, Citrus × tosa-asahi, Citrus × yatsushiro, Citrus × sinensis var. plumosa, Citrus × aurantium f. intermedia, Citrus × bigaradia var. corniculata, Citrus × bigaradia var. sulcata, Citrus grandis var. kotokan, Citrus × aurantium var. umbilicata, Citrus × vulgaris var. glaberrima, Citrus × sinensis subsp. hierochuntica, Citrus × aurantium var. amara, Citrus × aurantium var. balearica, Citrus × nobilis f. tumida, Citrus × aurantium var. limetta, Citrus × paradisi, Citrus × aurantium var. grassensis, Citrus × taiwanica, Citrus × aurantium var. mandarina, Citrus × leiocarpa var. tumida, Citrus × bigaradia var. violacea, Citrus × aurantium var. vulgaris, Aurantium × acre, Citrus sabon f. hakunikuyu, Citrus × bigaradia var. hispanica, Citrus × dulcimedulla, Citrus × aurantium var. mutabilis, Citrus × bigaradia var. coronata, Citrus × sulcata, Citrus sabon f. soyu, Citrus × aurantium var. limetiformis, Citrus × iyo, Aurantium × coronatum, Citrus × aurantium var. elliptica, Citrus × aurantium var. microcarpon, Citrus × aurantium var. sanguinea, Citrus × sinensis var. myrtifolia, Citrus × bigaradia var. spatafora, Citrus × aurantium var. fructo-minutissima, Citrus × aurantium var. torulosa, Citrus × bigaradia var. glaberrima, Citrus maxima var. uvacarpa, Citrus tarogayo, Citrus × vulgaris var. pulpa-duci, Citrus grandis var. glaberrima, Citrus × humilis, Citrus × funadoko, Citrus × bigaradia var. variegata, Citrus × aurantium var. melitensis, Citrus × nobilis var. genshokan, Citrus × ampullacea, Citrus × pseudoparadisi, Citrus × pseudogulgul, Citrus × aurantium var. limoniformis, Citrus × bigaradia var. canaliculata, Citrus × bigaradia var. sinensis, Citrus × dulcis, Citrus × aurantium var. fructo-variabili, Citrus × omikanto, Citrus × nobilis, Citrus × aurantium var. multiflora, Citrus × aurantium var. depressa, Citrus × aurantium var. gibbosa, Citrus × rumphii, Citrus × aurantium var. ruginosa, Citrus × nobilis var. kikaijimense, Citrus × aurantium subsp. amara, Citrus × communis, Citrus × sinensis var. longifolia, Citrus × vulgaris var. fuctu-maxima, Citrus grandis var. sulcata, Citrus grandis var. dulcis, Citrus × mitsuharu, Citrus × bigaradia var. gallesiana, Citrus × keraji, Citrus × vulgaris var. rugosa, Citrus × aurantium var. dulcis, Citrus × aurantium var. tarda, Citrus × fusca, Citrus × sinensis f. sekkan, Citrus × aurantium var. mammifera, Citrus × pomelana, Citrus decumana var. patoniana, Citrus × bigaradia var. cyathifera, Citrus × calot, Citrus grandis var. racemosa, Citrus × medioglobosa, Citrus × bigaradia var. salicifolia, Citrus × bigaradia var. caliculata, Citrus × aurantium var. fructo-variegata, Citrus × truncata, Aurantium × humile, Citrus × aurantium var. minutissima, Citrus × aurantium var. crispa, Citrus × tengu, Citrus × aurantium var. pyriformis, Citrus × sinensis var. aurantia, Citrus × tankan f. koshotankan, Citrus grandis var. natsudaidai, Citrus × vulgaris var. myrtifolia
Traditionally used for
- Digestion
- Sleep
Cautions & contraindications
- Pregnancy
- Breastfeeding
- Heart conditions
Western Herbalism Properties
Gallery
Botanical Description
Citrus × aurantium, commonly called sour orange, Seville orange, or bitter orange, is an evergreen tree in the Rutaceae family reaching up to 9 m in height and 6 m in spread at a medium rate of growth. The plant is believed to be an ancient hybrid of Citrus maxima (pomelo) and Citrus reticulata (mandarin). It produces glossy, dark green, ovate-lanceolate leaves with broadly winged petioles and bears highly fragrant white five-petalled hermaphroditic flowers from April to June, pollinated chiefly by bees. The fruit is a globose hesperidium 7-10 cm in diameter with a thick, rough, deep orange rind containing abundant essential oil glands and a tart, bitter, juicy pulp divided into segments. Native to southeastern Asia and naturalized across the Mediterranean and tropical Americas, the species is cultivated worldwide for its peel (used in marmalade and bitters), flowers (yielding neroli oil), leaves (petitgrain oil), and immature fruit (TCM Zhi Shi), and as rootstock for sweet citrus cultivars.
Active Constituents
p-Synephrine
Phenylethylamine protoalkaloid (adrenergic agonist)Concentration: The assay marker for the pharmacopoeial immature fruit; measured content ranged widely across cultivars and reached 1.40 percent in some Citrus sinensis material
The compound that makes this fruit a sympathomimetic drug rather than a bland digestive. It is a partial beta-3 and weak alpha-1 adrenergic agonist and raises the rate of fat oxidation during low to moderate intensity exercise at 2 to 3 mg/kg. In pooled placebo-controlled trials it raised systolic blood pressure by 6.37 mmHg and diastolic by 4.33 mmHg on prolonged use, without producing weight loss. It is the active most responsible for the cardiovascular adverse events reported with bitter orange supplements.
Octopamine
Phenylethylamine protoalkaloid (trace amine)Concentration: Minor adrenergic amine of the fruit, well below p-synephrine
A second adrenergic agonist of the fruit. It matters disproportionately for athletes: octopamine is subject to World Anti-Doping Agency reporting thresholds, and dietary and supplement exposure has been shown to exceed those thresholds under realistic consumption, risking an adverse analytical finding with no intent to dope.
Tyramine
Biogenic amineConcentration: Minor constituent of the fruit
The reason a monoamine oxidase inhibitor is a hard contraindication rather than a caution. Tyramine is normally destroyed by intestinal and hepatic MAO-A; when that enzyme is blocked it reaches the circulation and displaces noradrenaline from sympathetic nerve terminals, which is the mechanism of hypertensive crisis.
Neohesperidin
Flavanone neohesperidosideConcentration: 9.38 to 21.93 percent in Citrus aurantium fruit; only 0.03 to 0.14 percent in Poncirus trifoliata and Citrus wilsonii adulterants
Together with naringin it accounts for the intense bitterness of the drug and is the single best chemical discriminator between genuine material and the trifoliate-orange adulterants, which contain it only in trace amounts. Genuine material also contains hesperetin and tangeretin, which those adulterants lack entirely.
Naringin
Flavanone neohesperidosideConcentration: 3.96 to 15.21 percent in Citrus aurantium fruit; 33.7 percent of a supercritical antisolvent fraction of the flowers
The dominant bitter flavanone. Its aglycone naringenin is a weak inhibitor of CYP3A4 and of organic anion transporting polypeptides, though in citrus juices the furanocoumarins rather than the flavanones carry most of the clinically observed interaction.
Hesperidin
Flavanone rutinosideConcentration: Below 2.50 percent in Citrus aurantium fruit but above 10.00 percent in Citrus sinensis
Chiefly useful as an identity marker. Because the Chinese Pharmacopoeia permits both sour orange and sweet orange as sources of the immature fruit drug, hesperidin content is the practical way to tell which species was actually supplied: a hesperidin content over 10 percent indicates sweet orange, not sour orange.
Bergapten (5-methoxypsoralen)
Linear furanocoumarinConcentration: 31 micromolar in Seville orange juice; detected in Seville orange juice and not in grapefruit juice
A mechanism-based inhibitor of recombinant CYP3A4 and one of the constituents distinguishing sour orange from grapefruit. It inhibited CYP3A4 activity in cultured intestinal epithelial cells by 34 percent at 10 micromolar. It is also the classic phototoxic and photocarcinogenic psoralen, which matters for topical peel and oil preparations exposed to sunlight.
6',7'-Dihydroxybergamottin
Linear furanocoumarinConcentration: 36 micromolar in Seville orange juice, higher than the 23 micromolar of the dilute grapefruit juice it was compared against
The most potent CYP3A4 inhibitor of the group, cutting activity in cultured intestinal epithelial cells by 93 percent at 10 micromolar. Critically, it does not inhibit P-glycoprotein at concentrations up to 50 micromolar, which is why sour orange affects CYP3A4-limited drugs but not P-glycoprotein-limited ones.
Bergamottin
Linear furanocoumarinConcentration: 5 micromolar in Seville orange juice
Present at lower concentration than in grapefruit juice. It contributes to the CYP3A4 inactivation and, with 6',7'-dihydroxybergamottin, serves as a marker substance for foods likely to produce a grapefruit-type interaction.
⚠ Drug Interactions
Felodipine and other CYP3A4-limited calcium channel blockers
Demonstrated directly in a randomised three-way crossover in 10 volunteers: 240 mL of Seville orange juice raised felodipine area under the curve by 76 percent, against 93 percent for a grapefruit juice matched for bergamottin plus 6',7'-dihydroxybergamottin content. Peak concentration rose while terminal half-life was unchanged, the signature of presystemic rather than systemic inhibition. The mechanism is mechanism-based inactivation of intestinal CYP3A4 by the furanocoumarins, and it is long-lasting: with dextromethorphan as probe, bioavailability had returned only halfway to baseline after a three-day washout.
Clinical note: Treat sour orange preparations as a grapefruit-equivalent for CYP3A4-limited drugs. Because the inhibition is irreversible, separating doses by a few hours does not help; a washout of several days is needed. This applies to the fruit and juice and to any peel-containing preparation, including the herbal drugs made from it.
Ciclosporin and indinavir, and other drugs whose absorption is limited by P-glycoprotein
Recorded here because it is the boundary of the interaction, and getting it wrong in either direction causes harm. Seville orange juice reduced enterocyte CYP3A4 content by an average of 40 percent yet did not change ciclosporin exposure at all, while grapefruit juice raised ciclosporin area under the curve by 55 percent and peak concentration by 35 percent. The explanation is that 6',7'-dihydroxybergamottin does not inhibit P-glycoprotein up to 50 micromolar, and ciclosporin absorption is P-glycoprotein-limited. In a crossover study of 13 volunteers, sour orange juice likewise only delayed indinavir time to peak, from 1.25 to 1.87 hours, without altering exposure.
Clinical note: Do not extrapolate from grapefruit to sour orange for transplant immunosuppression; the ciclosporin interaction is a grapefruit effect, not a furanocoumarin effect. Equally, do not use that negative result to reassure a patient on felodipine, atorvastatin or another CYP3A4-limited drug, where the interaction is real and large.
Caffeine, ephedrine, pseudoephedrine, phenylephrine and other sympathomimetic stimulants
The extract is itself sympathomimetic. A meta-analysis of 18 placebo-controlled human trials found systolic pressure rose by 6.37 mmHg and diastolic by 4.33 mmHg after prolonged use, with a tendency to raise heart rate and no demonstrable weight loss to offset it. Bitter orange became the commonest ephedra replacement in slimming products after ephedra was withdrawn, and is usually combined with caffeine. A 38-year-old woman with no cardiovascular risk factors developed supraventricular tachycardia and a rise in high-sensitivity troponin I from 17.9 to 1,395.7 ng/L after one week of a bitter-orange weight-loss supplement, with pulmonary embolism and obstructive coronary disease excluded.
Clinical note: Do not combine with caffeine-containing stimulants, and avoid altogether in uncontrolled hypertension, arrhythmia, structural heart disease or a history of stimulant-related events. Bitter orange is not a benign herbal alternative to ephedra. The Chinese Pharmacopoeia advises caution in pregnancy for both fruit drugs, and LactMed advises nursing mothers avoid it, since the adrenergic amines may reduce milk production.
Monoamine oxidase inhibitors including phenelzine, tranylcypromine, moclobemide, selegiline, rasagiline and linezolid
The fruit contains tyramine and octopamine alongside p-synephrine, all substrates or releasers within the pathway that MAO inhibition disables. No controlled interaction study has been done with sour orange specifically, so the evidence is mechanistic and class-based rather than measured for this plant. Given that concentrated extracts multiply the amine load well beyond dietary exposure, the theoretical framing should not be read as reassurance.
Clinical note: Treat concentrated bitter orange extracts as contraindicated with any MAO inhibitor, including the antibiotic linezolid and the selective MAO-B agents used in Parkinson's disease. Dietary quantities of the whole fruit are a lesser concern than standardised synephrine extracts.
Anti-doping testing under World Anti-Doping Agency rules
Octopamine, a constituent of the fruit, is among the substances subject to WADA reporting thresholds, and modelling of dietary exposure and urinary excretion shows realistic consumption can exceed those thresholds. Separately, an analysis of 200 sports supplements bought in the Australian online market found 35 percent contained WADA prohibited substances, overwhelmingly stimulants, with fat burners and pre-workouts the highest-risk categories. Bitter orange is a standard ingredient of both.
Clinical note: Do not supply bitter orange preparations to an athlete subject to testing without checking the current WADA Prohibited List and Monitoring Program for each named amine, and prefer batch-certified products. The herbal origin of a substance confers no exemption.
Zhi Shi and Zhi Qiao adulterated with Poncirus trifoliata, Citrus wilsonii, Citrus maxima or mandarin cultivars
The immature fruit drug is drawn from Citrus aurantium and its many legally cultivated variants, and the proliferation of new cultivars has made the market difficult to police. A systematic quality study found that synephrine content complied with the Chinese Pharmacopoeia in all genuine samples but not in adulterants derived from Poncirus trifoliata, Citrus wilsonii, the Changshanhuyou cultivar or orah mandarins. The Poncirus and Citrus wilsonii materials most closely resemble the Daidai cultivar on appearance but carry neohesperidin at only 0.03 to 0.14 percent against 9.38 to 21.93 percent in genuine material, and lack hesperetin and tangeretin entirely.
Clinical note: Where the intended effect depends on the drug's qi-moving action, require a neohesperidin figure as well as a synephrine figure on the certificate of analysis; synephrine alone will not exclude a Poncirus substitution, and a hesperidin content above 10 percent indicates sweet orange rather than sour orange was supplied.
Evidence Tier
Strong evidence · 7 studiesRecorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.
Systematic review / meta-analysis
2
2 verified · 0 unverified
Randomized controlled trial
2
2 verified · 0 unverified
Other clinical trial
1
1 verified · 0 unverified
Observational / case report
1
0 verified · 1 unverified
In vitro / animal
0
Other / unclassified
1
1 verified · 0 unverified
Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description
Clinical Studies
The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine: A Systematic Review and Meta-Analysis
The best available synthesis of the human evidence, restricted to placebo-controlled trials and reported to PRISMA. Eighteen articles were meta-analysed. Both systolic and diastolic blood pressure rose significantly after prolonged use, by 6.37 mmHg (95 percent CI 1.02 to 11.72) and 4.33 mmHg (95 percent CI 0.48 to 8.18) respectively. Weight loss was not significant after prolonged treatment and body composition did not change. The conclusion is blunt: synephrine tends to raise blood pressure and heart rate, and there is no evidence it facilitates weight loss.
Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins
A randomised three-way crossover in 10 volunteers taking felodipine 10 mg extended-release with 240 mL of Seville orange juice, dilute grapefruit juice matched on furanocoumarin content, or common orange juice as negative control. Felodipine area under the curve rose 76 percent with Seville orange juice and 93 percent with grapefruit juice; peak concentration rose while terminal half-life was unchanged, indicating presystemic inhibition. Seville orange juice contained bergamottin at 5 and 6',7'-dihydroxybergamottin at 36 micromolar, plus bergapten at 31 micromolar which was absent from grapefruit juice and proved to be a mechanism-based CYP3A4 inhibitor. This is the study that establishes sour orange as a grapefruit-equivalent for CYP3A4.
6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein
A crossover comparison in healthy subjects, not randomised as reported. Grapefruit juice raised ciclosporin area under the curve by 55 percent and peak concentration by 35 percent, but Seville orange juice had no effect on ciclosporin disposition at all, even though it reduced enterocyte CYP3A4 content by an average of 40 percent in the two subjects biopsied. 6',7'-Dihydroxybergamottin did not inhibit P-glycoprotein at up to 50 micromolar. The finding delimits the interaction: sour orange inhibits intestinal CYP3A4 but does not touch P-glycoprotein, so drugs whose absorption is P-glycoprotein-limited are spared.
The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: The role of gut CYP3A and P-glycoprotein
A fixed-sequence crossover in 11 healthy volunteers over three weeks, with 30 mg dextromethorphan taken with 200 mL of water, grapefruit juice or Seville orange juice on separate days separated by three-day washouts. Dextromethorphan bioavailability rose significantly with both juices and had returned only to half the baseline value after three days of washout, which is the clearest human demonstration that the inhibition of gut CYP3A and P-glycoprotein by these juices is long-lasting and probably irreversible. The two juices had essentially the same overall effect.
Effect of Seville Orange Juice and Grapefruit Juice on Indinavir Pharmacokinetics
An open-label three-period crossover in 13 healthy volunteers given indinavir 800 mg eight-hourly for a day and a further 800 mg dose with 8 ounces of Seville orange juice, single-strength grapefruit juice or water. Sour orange juice significantly delayed time to peak, from 1.25 to 1.87 hours, but changed no other parameter; grapefruit juice changed nothing. The authors concluded presystemic metabolism contributes little to the wide interpatient variability in indinavir exposure. A useful negative result that keeps the CYP3A4 interaction from being over-generalised.
Therapeutic potential of Neroli Essential Oil (Citrus aurantium) in obstetrics and gynecology: A systematic review
A PRISMA 2020 review of 12 randomised controlled trials in 1,170 women aged 15 to 80, using neroli oil distilled from the flowers of this species, applied by inhalation rather than taken internally. Narrative synthesis, because of clinical heterogeneity, reported reduced pain in primary dysmenorrhoea and labour, reduced premenstrual symptoms, lower anxiety and depression in pregnancy, better sleep, and less nausea and vomiting in pregnancy and chemotherapy. Note the plant part and route: none of the p-synephrine cardiovascular concerns attach to inhaled flower oil, and none of this evidence supports oral fruit preparations.
Effects of p-Synephrine during Exercise: A Brief Narrative Review
A narrative rather than systematic synthesis, included for its dose specificity. Acute p-synephrine did not change sprint performance, jumping capacity or aerobic capacity, but at 2 to 3 mg/kg body mass it raised the maximal rate of fat oxidation during exercise between 30 and 80 percent of peak oxygen uptake, with a matching fall in carbohydrate use and no change in total energy expenditure or heart rate. Whether the effect survives chronic dosing, and whether it translates into body fat loss, remains untested; the placebo-controlled meta-analysis found no weight loss.
Historical Texts
Shennong Bencao Jing
Han dynasty, compiled c. 200 CELeigong Paozhi Lun
Liu Song dynasty, c. 5th century CEReferences
- Plaitis A, Grigoraki E, Karakosta M, Gardikioti V, Kalesi AE, Kalivi A, Giannakodimos A, Barmpagiannis D, Theodosis-Georgilas A, Patsourakos N. Unexplained Supraventricular Tachycardia and Myocardial Injury After Bitter Orange Supplement Use in a Young Woman . JACC: Case Reports (2026) [DOI]
- Liu HY, Xue BX, Li C, Ou ZM, Wang ZM, Yi H, Liu XQ. [Quality identification of Aurantii Fructus Immaturus from different origins and their adulterants]. . China Journal of Chinese Materia Medica (Zhongguo Zhong Yao Za Zhi) (2024) [DOI]
- Park H, Son J. Proactive surveillance of foodborne bioactives by integrated dietary exposure and urinary excretion assessment . npj Science of Food (2026) [DOI]
- Barker L, Cawley A, Speers N, Knowler K, Chilman K. Sports Supplement Analysis Survey for the Prevalence of WADA Prohibited Substances in the Australian Online Marketplace . Drug Testing and Analysis (2025) [DOI]
- Trabelsi D, Martínez-López JF, Abderrabba M, Urieta JS, Mainar AM. Supercritical CO2 Antisolvent Fractionation of Citrus aurantium Flower Extracts: Enrichment and Characterization of Bioactive Compounds . Plants (2025) [DOI]
- Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development. Bitter Orange . Drugs and Lactation Database (LactMed), Bethesda (MD) (2006)
- Plants of the World Online, Royal Botanic Gardens Kew. Citrus x aurantium L.: accepted name of the hybrid orange complex, under which Citrus sinensis (sweet orange) is placed in synonymy . Plants of the World Online (2026)
This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.
📝 Notes
Public notes from the community and your own private notes on Sour orange.
No notes yet.